According to the National Comprehensive Cancer Network and the European LeukemiaNet (ELN) 2017, AML cases with cytogenetically normal karyotypes and FLT3/ITD mutation have a poor prognosis. The gene discussed is FLT3; the disease is acute myeloid leukemia.